Seminars in Clinical Psychopharmacology
edited by Peter M. Haddad, David J. Nutt.
Bok Engelsk 2020 · Electronic books.
| Medvirkende | |
|---|---|
| Omfang | 1 online resource (xxiv, 665 pages) : : digital, PDF file(s).
|
| Utgave | Third edition.
|
| Opplysninger | Title from publisher's bibliographic system (viewed on 01 Jun 2020).. - Cover -- Half-title page -- Series page -- Title page -- Copyright page -- Contents -- List of Contributors -- Foreword -- Preface -- Editor's Note on Nomenclature -- Neuroscience-Based Nomenclature Glossary -- List of Abbreviations -- Part 1 Basic Science and General Principles -- Chapter 1 A Brief History of Psychopharmacology -- Chapter 2 Psychiatric Drug Discovery and Development -- Chapter 3 Neurotransmission and Mechanisms of Drug Action -- Chapter 4 Pharmacodynamics and Pharmacokinetics: Stuart Banham and David Taylor -- Chapter 5 Pharmacogenomics and Psychopharmacology -- Chapter 6 Good Clinical Practice in Psychopharmacology -- Part 2 Psychopharmacology of the Main Psychotropic Drug Groups -- Chapter 7 Drugs to Treat Depression -- Chapter 8 Drugs to Treat Anxiety and Insomnia -- Chapter 9 Drugs to Treat Schizophrenia and Psychosis (Dopamine Antagonists and Partial Agonists Other Than Clozapine) -- Chapter 10 Clozapine -- Chapter 11 Lithium -- Chapter 12 Anticonvulsants for Mental Disorders: Valproate, Lamotrigine, Carbamazepine and Oxcarbazepine -- Chapter 13 Drugs to Treat Attention Deficit Hyperactivity Disorder (ADHD) -- Chapter 14 Drugs to Treat Dementia -- Chapter 15 Drugs to Treat Substance Use Disorders -- Chapter 16 Electroconvulsive Therapy and Neuromodulation Therapies -- Part 3 Specific Therapeutic Areas -- Chapter 17 Psychotropic Drug Treatment in Childhood and Adolescence -- Chapter 18 Psychotropic Drug Treatment in Later Life -- Chapter 19 Psychotropic Prescribing in Pregnancy and Lactation -- Chapter 20 The Clinical Management of Acute Disturbance Including Rapid Tranquillisation -- Chapter 21 Antipsychotics, Weight Gain and Metabolic Risk -- Index.. - This greatly expanded third edition provides a comprehensive overview of clinical psychopharmacology, incorporating the major advances in the field since the previous edition's publication. Renowned experts from psychiatry, pharmacy, and nursing have integrated basic science, psychopharmacology, and clinical practice throughout the book in order to provide a thorough basis for prescribing. It covers all key psychiatric drugs and disorders and includes the latest data on efficacy, safety and tolerability. Adopting a pragmatic approach to drug nomenclature, both Neuroscience-based Nomenclature (NbN) and older generic terminology are included in the text reflecting that clinicians are likely to use both systems. Many chapters refer to current National Institute of Health and Care Excellence (NICE) guidelines, making this a crucial resource. Edited by leading authorities in the field, Professor Peter M. Haddad and Professor David J. Nutt, Seminars in Clinical Psychopharmacology emphasises evidence-based prescribing with the aim of achieving better clinical outcomes for patients.
|
| Emner | |
| Sjanger | |
| Dewey | |
| ISBN | 1-911623-46-X
|
